骨骼肌脂肪浸润与重症哮喘患者肺功能轨迹
研究基于SARP III队列,分析219例哮喘患者与37例健康对照的椎旁肌密度(PSMD,反映肌肉脂肪浸润)与纵向支气管舒张后FEV1%预计值的关系。哮喘患者调整后PSMD低于对照(42.2 vs 55.8 HU,P<0.001);女性哮喘患者基线PSMD可预测肺功能下降,男性无此关联。
要点
- 哮喘患者椎旁肌密度低于健康对照,提示肌肉脂肪浸润更多
- 女性哮喘患者基线PSMD越低,5年FEV1%预计值下降越明显
- 男性哮喘患者中未观察到PSMD与肺功能轨迹的关联
核心结论
- 哮喘患者椎旁肌密度更低,反映肌肉脂肪浸润更重。
- 基线PSMD可预测女性哮喘患者的肺功能下降,男性无此预测作用。
- 结果支持代谢功能障碍在肺功能下降中起重要作用。
研究设计与样本
- SARP III成年参与者中基线有CT影像且纵向随访支气管舒张后FEV1%预计值者。
- 计算第12胸椎体左右椎旁肌密度均值(HU),并从不患哮喘的健康对照推导参考范围。
- 采用线性多变量混合效应模型,按性别分层评估基线PSMD与肺功能轨迹的关联。
- 随访中位5年(1,132人年)。
主要发现
- 哮喘患者219例(女性67%,平均BMI 32.3 kg/m2),对照37例(女性51%,平均BMI 26.3 kg/m2)。
- 哮喘患者调整后PSMD低于对照(42.2 vs 55.8 HU;P<0.001)。
- 女性哮喘患者中PSMD预测肺功能轨迹(每降低10 HU,斜率变化β=-0.47;P=0.03)。
- 男性哮喘患者中未见关联(每降低10 HU,β=0.11;P=0.77)。
- 女性哮喘患者5年内,PSMD最高三分位预测FEV1%预计值改善2.9%,最低三分位预测下降1.8%。
临床怎么用
- 对女性哮喘患者可关注骨骼肌脂肪浸润这一肺功能下降的潜在预测因素。
- PSMD测量基于胸部CT椎旁肌密度,可作为评估代谢功能障碍的影像学指标。
- 男性哮喘患者中PSMD的预测价值有限,解读时应按性别分层。
局限性
- 研究为观察性设计,PSMD与肺功能轨迹的关联不能确立因果。
- 仅纳入有基线CT影像的SARP III参与者,存在选择偏倚可能。
- 男性哮喘患者样本量相对有限,阴性结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Extrapulmonary manifestations of asthma, including fatty infiltration in tissues, may reflect systemic inflammation and influence lung function and disease severity. Objectives: To determine if skeletal muscle adiposity predicts lung function trajectory in asthma. Methods: Adult SARP III (Severe Asthma Research Program III) participants with baseline computed tomography imaging and longitudinal postbronchodilator FEV1% predicted (median follow-up 5 years [1,132 person-years]) were evaluated. The mean of left and right paraspinous muscle density (PSMD) at the 12th thoracic vertebral body was calculated (Hounsfield units [HU]). Lower PSMD reflects higher muscle adiposity. We derived PSMD reference ranges from healthy control subjects without asthma. A linear multivariable mixed-effects model was constructed to evaluate associations of baseline PSMD and lung function trajectory stratified by sex. Measurements and Main Results: Participants included 219 with asthma (67% women; mean [SD] body mass index, 32.3 [8.8] kg/m2) and 37 control subjects (51% women; mean [SD] body mass index, 26.3 [4.7] kg/m2). Participants with asthma had lower adjusted PSMD than control subjects (42.2 vs. 55.8 HU; P < 0.001). In adjusted models, PSMD predicted lung function trajectory in women with asthma (β = -0.47 Δ slope per 10-HU decrease; P = 0.03) but not men (β = 0.11 Δ slope per 10-HU decrease; P = 0.77). The highest PSMD tertile predicted a 2.9% improvement whereas the lowest tertile predicted a 1.8% decline in FEV1% predicted among women with asthma over 5 years. Conclusions: Participants with asthma have lower PSMD, reflecting greater muscle fat infiltration. Baseline PSMD predicted lung function decline among women with asthma but not men. These data support an important role of metabolic dysfunction in lung function decline.
引用
- Tattersall MC, Lee KE, Tsuchiya N, et al. Skeletal Muscle Adiposity and Lung Function Trajectory in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2023. PMID: 36194556. doi:10.1164/rccm.202203-0597OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。